Intertek Announces the Expansion and Relocation of Its Bioanalytical LC-MS Facility
March 06 2015 - 4:00AM
Business Wire
Strengthening clinical development support for pharmaceutical
clients worldwide
Intertek, a leading quality solutions provider to industries
worldwide, announced the expansion and relocation of its
bioanalytical liquid chromatography– mass spectrometry (LC-MS)
facility in El Dorado Hills, California to Intertek’s existing
center of excellence facility in San Diego.
The relocation to the San Diego facility will be completed by
June 2015. The increased laboratory capacity of the San Diego
facility, which spans 46,000 square feet of laboratories, offices
and sample storage, will benefit customers involved in preclinical
and clinical small molecule drug development. This will be coupled
with investment in new state-of-the-art mass spectrometers which
will be operational at the new San Diego LC-MS facility prior to
relocation and so avoid service delivery interruption.
Existing large molecule bioanalysis services from the
immunochemistry laboratory in San Diego will be strengthened by
expanded capability for bioanalytical LC-MS evaluation of biologic
drugs such as proteins, antibody therapeutics or biosimilars as a
result of the relocation and investment.
Chetan Parmar, Senior Vice President of Intertek Life Sciences,
said “Expanding and consolidating our bioanalytical capacity will
strengthen our capability to address the challenges our clients
encounter during increasingly complex drug development programs and
provide them with the right data for informed decision-making".
Intertek has been providing Good Laboratory Practice (GLP)
compliant bioanalytical services to global pharmaceutical clients
supporting their preclinical and clinical studies for over 20 years
and the combined bioanalytical LC-MS/immunochemistry facility will
be a key part of Intertek’s network of state-of-the art
GLP-compliant laboratories.
More information:
http://www.intertek.com/pharmaceutical/bioanalysis/
About Intertek
Intertek is a leading quality solutions provider to industries
worldwide. From auditing and inspection, to testing, training,
advisory, quality assurance and certification, Intertek adds value
for its customers by helping improve the quality and safety of
their products, assets and processes. With a network of more than
1,000 laboratories and offices and over 36,000 people in more than
100 countries, Intertek supports companies’ success in the global
marketplace, by helping customers to meet end users’ expectations
for safety, sustainability, performance, integrity and desirability
in virtually any market worldwide. Visit www.intertek.com.
Intertek Pharmaceutical ServicesDr Lorna KettleMarketing
ManagerTel.:+44 161 721 1476Email: lorna.kettle@intertek.com
Intertek (LSE:ITRK)
Historical Stock Chart
From Aug 2024 to Sep 2024
Intertek (LSE:ITRK)
Historical Stock Chart
From Sep 2023 to Sep 2024